What You Should Know:
– Global healthcare technology leader Philips has announced the release of Transcend Plus, the next generation of its EPIQ CVx and Affiniti CVx cardiovascular ultrasound systems.
– The new system features major advancements in image quality and artificial intelligence (AI), including new FDA-cleared 2D and 3D image quality enhancements and an expanded suite of AI-enabled clinical applications. Transcend Plus is designed to help cardiology teams work smarter, not harder, to address growing challenges like increased patient volume, rising clinical complexity, and staffing shortages.
AI-Powered Cardiovascular Ultrasound System
Transcend Plus visibly improves sharpness, contrast, and detail in 2D and 3D imaging, with the latest FDA-cleared enhancements for the EPIQ CVx and Affiniti CVx systems. These upgrades support superior visualization of cardiac anatomy and function, which helps improve diagnostic confidence, even in complex cases. The system also introduces the new 2D Auto EF Advanced feature, which expands AI capabilities for contrast images and is essential for accurately assessing cardiac function.
Philips now offers 26 FDA-cleared cardiovascular ultrasound AI applications, which is the most in the industry. These applications are fully integrated into Transcend Plus for both EPIQ and Affiniti CVx systems. Among the latest enhancements to receive FDA clearance are 2D Auto EF and 2D Auto EF Advanced. These tools are designed to streamline clinical workflows and improve diagnostic accuracy across a range of care settings.
“Artificial intelligence is a tool, not a threat, and I always maintain that human plus AI is going to be better than human alone or AI alone – the 3D Auto CFQ and 3D Auto TV AI applications are examples of this, taking manual, time-consuming processes and automating these measurements in a fast, easy and reproducible way,” said Akhil Narang, MD, Director, Echocardiography Laboratory and Associate Professor of Medicine, Division of Cardiology at the Feinberg School of Medicine, Northwestern University and Bluhm Cardiovascular Institute.
A key application in cardiac imaging is left ventricular (LV) function assessment. Transcend Plus supports this need by delivering fast, reproducible results that help cardiologists quickly and consistently evaluate LV function across different patients and over time. Automated tools minimize operator variability, ensuring more reliable and standardized measurements.
Philips Ultrasound systems are estimated to perform 1.33 billion diagnostic and interventional procedures each year, supporting diagnosis and treatment for 654 million unique patients annually.
